Standing Stone’s CholesterolClinic™ V3.2 Delivers Improved Patient Outcomes and Cost Savings for Cholesterol Therapy Management
Full-Featured Clinical Decision Support Software Benefits Both Patients and Healthcare Providers

WESTPORT, CT -- (Business Wire) --

December 17, 2007
By Cheryl Lechok

Standing Stone, Inc., a leader in disease state management solutions, announces the release of its CholesterolClinic™ software Version 3.2 with significantly expanded reporting and user functionality. The enhanced user interface provides the most comprehensive, easy-to-use cholesterol clinical decision support solution available to healthcare professionals today.

New CholesterolClinic™ options include built-in enhanced reporting capabilities, and a new statistical report automatically shows the number of patients at goal for HDL, LDL and triglycerides. The software’s “look and feel” emulates the company’s flagship CoagClinic™ module.

CholesterolClinic™ incorporates many features not available with other lipid therapy management tools such as multiple dosing algorithms, customized patient education, NCEP III guidelines and Framingham Heart scores. Additional information on CholesterolClinic™ can be found at http://www.standingstoneinc.com/ehealth_cholesterol.html.

Patient benefits of CholesterolClinic™ include improved compliance with therapy, increased access to education and support, faster turnaround time and greater patient satisfaction. Healthcare professionals benefit from fewer patient complications, better decision support and outcomes tracking and the ability to process more patients. For clinic administrators, patient visit reimbursements can generate new, recurring revenues, costs due to complications from therapy are lower and overhead can be dramatically reduced by up to 75%.

From 1999-2006 average cholesterol levels for U.S. adults dropped below 200, considered ideal, according to figures released last week by the CDC. The increased use of cholesterol-lowering medications is believed a key factor.

"This release of CholesterolClinic™ continues our company’s mission to provide affordable clinical decision support tools to healthcare professionals engaged in the daily battle to better manage their patients," said Albert J. Bartosic, President of Standing Stone. He continued, "We are proud to develop applications that meet the demanding needs of our customers and help them improve patient outcomes."

About Standing Stone, Inc.

Standing Stone (www.standingstoneinc.com), founded in 1998, is a disease state management company dedicated to enhancing the quality of care provided to patients who require long-term therapy for chronic disease management. The firm’s sophisticated web-based software applications are designed for use in clinical settings such as hospital systems, dedicated clinics or physician’s offices and can be securely accessed via the Internet.

Press Contact:
Cheryl Lechok
203.227.8710 X217
clechok@standingstoneinc.com

 

49 Richmondville Avenue, Westport, CT 06880   Tel: (800) 648-9877   E-mail: info@standingstoneinc.com